Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
10.54
-0.93 (-8.11%)
At close: Sep 29, 2026, 4:00 PM EDT
10.59
+0.05 (0.47%)
After-hours: Sep 29, 2026, 7:54 PM EDT
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $754.02 million as of September 29, 2026. Its market cap has increased by 1,009.78% in one year.
Market Cap
754.02M
Enterprise Value
522.92M
1-Year Change
1,009.78%
Ranking
Category
Stock Price
$10.54
ChartMarket Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $754.02M, an increase of 1,046.92%. That is a compound annual growth rate of 66.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 754.02M | 173.60% |
| Dec 31, 2025 | 275.60M | 355.41% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Achieve Life Sciences | 791.32M |
| Design Therapeutics | 789.78M |
| Annexon | 782.96M |
| Aclaris Therapeutics | 777.21M |
| Gyre Therapeutics | 776.17M |
| Inventiva | 768.41M |
| Solid Biosciences | 767.73M |
| Olema Pharmaceuticals | 747.23M |